PT-141, also known as Bremelanotide, is a synthetic peptide primarily recognized for its effects on sexual function and the enhancement of libido. Unlike conventional treatments for sexual dysfunction that focus on vascular mechanisms, PT-141 acts directly on the central nervous system by targeting melanocortin receptors. This unique approach allows it to influence sexual desire and arousal without depending on changes in blood flow, making it an alternative option for individuals dealing with low libido or related concerns. It has been studied in both men and women, and its ability to stimulate desire has made it of interest in both therapeutic and wellness settings.

​

PT-141 works by binding to melanocortin receptors in the brain, particularly the MC3 and MC4 receptors, which play a role in regulating sexual behavior and energy balance. Activation of these receptors initiates neural pathways that increase sexual motivation and responsiveness. This central mode of action sets it apart from medications like PDE5 inhibitors, which primarily address physical performance rather than desire. Although PT-141 may be effective in supporting sexual function, it can also produce side effects such as nausea or flushing, so it should be used with care and appropriate guidance.